Background: On diagnosing Alzheimer’s disease (AD), most existing imaging-based schemes have relied on analyzing the hippocampus and its peripheral structures. Recent studies have confirmed that volumetric variations are one of the primary indicators in differentiating symptomatic AD from healthy aging. In this study, we focused on deriving discriminative shape-based parameters that could effectively identify early AD from volumetric computerized tomography (VCT) delineation, which was previously almost intangible. Methods: Participants were 63 volunteers of Thai nationality, whose ages were between 40 and 90 years old. Thirty subjects (age 68.51 ± 5.5) were diagnosed with early AD, by using Diagnostic and Statistical Manual of Mental Disor...
Here, we examine morphological changes in cortical thickness of patients with Alzheimer`s disease (A...
Background and Aim: For effective treatment of Alzheimerchr('39')s disease (AD), it is important to ...
MRI is an important clinical tool for diagnosing dementia-like diseases such as Frontemporal Dementi...
Background: On diagnosing Alzheimer’s disease (AD), most existing imaging-based schemes have relied ...
Alzheimer disease (AD) is a neurodegenerative disease characterized by progressive dementia. The hip...
The hippocampus is affected at an early stage in the development of Alzheimer's disease (AD). With t...
Item does not contain fulltextThe hippocampus is affected at an early stage in the development of Al...
International audienceWe describe a new method to automatically discriminate between patients with A...
BACKGROUND AND PURPOSE: Alzheimer disease (AD) is a neurodegenerative disease characterized by progr...
International audience. The hippocampus is affected at an early stage in the development of Alzheime...
International audienceThe hippocampus is among the first structures affected in Alzheimer's disease ...
A trophy and other brain changes, which are typical of aging, generate wide inter-individual variabi...
Background: Hippocampal atrophy - particularly of the CA1 region - may be useful as a biomarker for ...
Atrophy and other brain changes, which are typical of aging, generate wide inter-individual variabil...
Here, we examine morphological changes in cortical thickness of patients with Alzheimer`s disease (A...
Background and Aim: For effective treatment of Alzheimerchr('39')s disease (AD), it is important to ...
MRI is an important clinical tool for diagnosing dementia-like diseases such as Frontemporal Dementi...
Background: On diagnosing Alzheimer’s disease (AD), most existing imaging-based schemes have relied ...
Alzheimer disease (AD) is a neurodegenerative disease characterized by progressive dementia. The hip...
The hippocampus is affected at an early stage in the development of Alzheimer's disease (AD). With t...
Item does not contain fulltextThe hippocampus is affected at an early stage in the development of Al...
International audienceWe describe a new method to automatically discriminate between patients with A...
BACKGROUND AND PURPOSE: Alzheimer disease (AD) is a neurodegenerative disease characterized by progr...
International audience. The hippocampus is affected at an early stage in the development of Alzheime...
International audienceThe hippocampus is among the first structures affected in Alzheimer's disease ...
A trophy and other brain changes, which are typical of aging, generate wide inter-individual variabi...
Background: Hippocampal atrophy - particularly of the CA1 region - may be useful as a biomarker for ...
Atrophy and other brain changes, which are typical of aging, generate wide inter-individual variabil...
Here, we examine morphological changes in cortical thickness of patients with Alzheimer`s disease (A...
Background and Aim: For effective treatment of Alzheimerchr('39')s disease (AD), it is important to ...
MRI is an important clinical tool for diagnosing dementia-like diseases such as Frontemporal Dementi...